Lower Cognitive and Psychiatric Adverse Events During Adjunctive Cenobamate

Cenobamate may be a suitable treatment option for patients who experience cognitive or psychiatric treatment-emergent adverse events with their current ASMs. In this MEDtalk, William E. Rosenfeld, MD, part-time consultant and advisor at SK Life Science, USA, presents two studies of cenobamate treatment.